Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention: A meta-analysis

BACKGROUND: In this analysis, we aimed to compare the efficacy and safety of dual therapy (DT) with a non-vitamin K oral anticoagulant (NOAC) and an adenosine diphosphate receptor antagonist (P2Y12 inhibitor) vs triple therapy (TT) with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Yang, Keping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052048/
https://www.ncbi.nlm.nih.gov/pubmed/33847681
http://dx.doi.org/10.1097/MD.0000000000025546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052048/
https://www.ncbi.nlm.nih.gov/pubmed/33847681
http://dx.doi.org/10.1097/MD.0000000000025546

Ejemplares similares